Regenerative Matrix Therapy™ is grounded in biology and guided by research. This page is updated regularly with original educational content that relates to our treatment philosophy, as well as summaries of published clinical studies and peer-reviewed trials on treatments that share foundational similarities with our approach.
While many of the featured studies reflect the growing body of evidence supporting biologic and regenerative therapies, Regenerative Matrix Therapy™ is built upon and enhanced from this foundation — representing a next-generation application designed with precision, personalization, and performance in mind.
Each article is written to make the data understandable and relevant — for both physicians and curious patients — while maintaining scientific accuracy and integrity.
A 2-year randomized controlled trial demonstrated adipose therapy was superior to PRP for knee osteoarthritis (OA), especially in moderate-to-severe OA.
2023 study confirms adipose therapy provides significant relief that lasts at least 3 years in 80% of knee OA patients.
In a 302-patient multicenter trial, Adipose Therapy provided superior and longer-lasting relief than hyaluronic acid for knee osteoarthritis (OA) over 24 months
2023 clinical trial found adipose therapy and bone marrow concentrate were equivalent and very effective in treating moderate-to-severe knee osteoarthritis.
A 2022 study (randomized controlled trial) shows adipose tissue added during rotator cuff repair improves early shoulder function, strength, and recovery speed.
Large 2022 hip OA study: adipose therapy (MFAT) ± PRP improved pain and function at 1 year, with no serious events reported.